|
1
|
Galipeau J and Sensébé L: Mesenchymal
stromal cells: Clinical challenges and therapeutic opportunities.
Cell Stem Cell. 22:824–833. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Huppert LA, Liu KD and Matthay MA:
Therapeutic potential of mesenchymal stromal cells in the treatment
of ARDS. Transfusion. 59:869–875. 2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Schwede M, Wilfong EM, Zemans RL, Lee PJ,
Dos Santos C, Fang X and Matthay MA: Effects of bone marrow-derived
mesenchymal stromal cells on gene expression in human alveolar type
II cells exposed to TNF-α, IL-1β, and IFN-γ. Physiol Rep.
6(e13831)2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Visweswaran M, Pohl S, Arfuso F, Newsholme
P, Dilley R, Pervaiz S and Dharmarajan A: Multi-lineage
differentiation of mesenchymal stem cells-to Wnt, or not Wnt. Int J
Biochem Cell Biol. 68:139–147. 2015.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Logan CY and Nusse R: The Wnt signaling
pathway in development and disease. Annu Rev Cell Dev Biol.
20:781–810. 2004.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Etheridge SL, Spencer GJ, Heath DJ and
Genever PG: Expression profiling and functional analysis of wnt
signaling mechanisms in mesenchymal stem cells. Stem Cells.
22:849–860. 2004.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Sasaki T, Han F, Shioda N, Moriguchi S,
Kasahara J, Ishiguro K and Fukunaga K: Lithium-induced activation
of Akt and CaM kinase II contributes to its neuroprotective action
in a rat microsphere embolism model. Brain Res. 1108:98–106.
2006.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Mao B, Wu W, Davidson G, Marhold J, Li M,
Mechler BM, Delius H, Hoppe D, Stannek P, Walter C, et al: Kremen
proteins are Dickkopf receptors that regulate Wnt/beta-catenin
signaling. Nature. 417:664–667. 2002.PubMed/NCBI View Article : Google Scholar
|
|
9
|
van Haaften T, Byrne R, Bonnet S,
Rochefort GY, Akabutu J, Bouchentouf M, Rey-Parra GJ, Galipeau J,
Haromy A, Eaton F, et al: Airway delivery of mesenchymal stem cells
prevents arrested alveolar growth in neonatal lung injury in rats.
Am J Respir Crit Care Med. 180:1131–1142. 2009.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Leeman KT, Pessina P, Lee JH and Kim CF:
Mesenchymal stem cells increase alveolar differentiation in lung
progenitor organoid cultures. Sci Rep. 9(6479)2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Liu AR, Liu L, Chen S, Yang Y, Zhao HJ,
Liu L, Guo FM, Lu XM and Qiu HB: Activation of canonical wnt
pathway promotes differentiation of mouse bone marrow-derived MSCs
into type II alveolar epithelial cells, confers resistance to
oxidative stress, and promotes their migration to injured lung
tissue in vitro. J Cell Physiol. 228:1270–1283. 2013.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Beshiri ML, Holmes KB, Richter WF, Hess S,
Islam AB, Yan Q, Plante L, Litovchick L, Gévry N, Lopez-Bigas N, et
al: Coordinated repression of cell cycle genes by KDM5A and E2F4
during differentiation. Proc Natl Acad Sci USA. 109:18499–18504.
2012.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Petrov N, Zhidkova O, Serikov V, Zenin V
and Popov B: Induction of Wnt/β-catenin signaling in mouse
mesenchymal stem cells is associated with activation of the p130
and E2f4 and formation of the p130/Gsk3β/β-catenin complex. Stem
Cells Dev. 21:589–597. 2012.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Zhang X, Chen J, Liu A, Xu X, Xue M, Xu J,
Yang Y, Qiu H and Guo F: Stable overexpression of p130/E2F4 affects
the multipotential abilities of bone-marrow-derived mesenchymal
stem cells. J Cell Physiol. 233:9739–9749. 2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Matthay MA, Calfee CS, Zhuo H, Thompson
BT, Wilson JG, Levitt JE, Rogers AJ, Gotts JE, Wiener-Kronish JP,
Bajwa EK, et al: Treatment with allogeneic mesenchymal stromal
cells for moderate to severe acute respiratory distress syndrome
(START study): A randomised phase 2a safety trial. Lancet Respir
Med. 7:154–162. 2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Laffey JG and Matthay MA: Fifty years of
research in ARDS. Cell-based therapy for acute respiratory distress
syndrome. biology and potential therapeutic value. Am J Respir Crit
Care Med. 196:266–273. 2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Wilson JG, Liu KD, Zhuo H, Caballero L,
McMillan M, Fang X, Cosgrove K, Vojnik R, Calfee CS, Lee JW, et al:
Mesenchymal stem (stromal) cells for treatment of ARDS: A phase 1
clinical trial. Lancet Respir Med. 3:24–32. 2015.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Walter J, Ware LB and Matthay MA:
Mesenchymal stem cells: Mechanisms of potential therapeutic benefit
in ARDS and sepsis. Lancet Respir Med. 2:1016–1026. 2014.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Ling L, Nurcombe V and Cool SM: Wnt
signaling controls the fate of mesenchymal stem cells. Gene.
433:1–7. 2009.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Cai SX, Liu AR, He HL, Chen QH, Yang Y,
Guo FM, Huang YZ, Liu L and Qiu HB: Stable genetic alterations of
β-catenin and ROR2 regulate the Wnt pathway, affect the fate of
MSCs. J Cell Physiol. 229:791–800. 2014.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Liu A, Chen S, Cai S, Dong L, Liu L, Yang
Y, Guo F, Lu X, He H, Chen Q, et al: Wnt5a through noncanonical
Wnt/JNK or Wnt/PKC signaling contributes to the differentiation of
mesenchymal stem cells into type II alveolar epithelial cells in
vitro. PLoS One. 9(e90229)2014.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Cai SX, Liu AR, Chen S, He HL, Chen QH, Xu
JY, Pan C, Yang Y, Guo FM, Huang YZ, et al: The orphan receptor
tyrosine kinase ROR2 facilitates MSCs to repair lung injury in ARDS
animal model. Cell Transplant. 25:1561–1574. 2016.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Capasso S, Alessio N, Di Bernardo G,
Cipollaro M, Melone MA, Peluso G, Giordano A and Galderisi U:
Silencing of RB1 and RB2/P130 during adipogenesis of bone marrow
stromal cells results in dysregulated differentiation. Cell Cycle.
13:482–490. 2014.PubMed/NCBI View
Article : Google Scholar
|
|
24
|
Matthay MA, Robriquet L and Fang X:
Alveolar epithelium: Role in lung fluid balance and acute lung
injury. Proc Am Thorac Soc. 2:206–213. 2005.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Mason RJ: Thoughts on the alveolar phase
of COVID-19. Am J Physiol Lung Cell Mol Physiol. 319:L115–L120.
2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Ruaro B, Salton F, Braga L, Wade B,
Confalonieri P, Volpe MC, Baratella E, Maiocchi S and Confalonieri
M: The history and mystery of alveolar epithelial type II cells:
Focus on their physiologic and pathologic role in lung. Int J Mol
Sci. 22(2566)2021.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Rojas M, Xu J, Woods CR, Mora AL, Spears
W, Roman J and Brigham KL: Bone marrow-derived mesenchymal stem
cells in repair of the injured lung. Am J Respir Cell Mol Biol.
33:145–152. 2005.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Ma N, Gai H, Mei J, Ding FB, Bao CR,
Nguyen DM and Zhong H: Bone marrow mesenchymal stem cells can
differentiate into type II alveolar epithelial cells in vitro. Cell
Biol Int. 35:1261–1266. 2011.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Li H, Ghazanfari R, Zacharaki D, Lim HC
and Scheding S: Isolation and characterization of primary bone
marrow mesenchymal stromal cells. Ann N Y Acad Sci. 1370:109–118.
2016.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Ortiz LA, Gambelli F, McBride C, Gaupp D,
Baddoo M, Kaminski N and Phinney DG: Mesenchymal stem cell
engraftment in lung is enhanced in response to bleomycin exposure
and ameliorates its fibrotic effects. Proc Natl Acad Sci USA.
100:8407–8411. 2003.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Yamada M, Kubo H, Kobayashi S, Ishizawa K,
Numasaki M, Ueda S, Suzuki T and Sasaki H: Bone marrow-derived
progenitor cells are important for lung repair after
lipopolysaccharide-induced lung injury. J Immunol. 172:1266–1272.
2004.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Kotton DN, Ma BY, Cardoso WV, Sanderson
EA, Summer RS, Williams MC and Fine A: Bone marrow-derived cells as
progenitors of lung alveolar epithelium. Development.
128:5181–5188. 2001.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Chen QH, Liu AR, Qiu HB and Yang Y:
Interaction between mesenchymal stem cells and endothelial cells
restores endothelial permeability via paracrine hepatocyte growth
factor in vitro. Stem Cell Res Ther. 6(44)2015.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Shannon JM, Mason RJ and Jennings SD:
Functional differentiation of alveolar type II epithelial cells in
vitro: Effects of cell shape, cell-matrix interactions and
cell-cell interactions. Biochim Biophys Acta. 931:143–156.
1987.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Olsen CO, Isakson BE, Seedorf GJ, Lubman
RL and Boitano S: Extracellular matrix-driven alveolar epithelial
cell differentiation in vitro. Exp Lung Res. 31:461–482.
2005.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Zeng M, Chen Q, Ge S, He W, Zhang L, Yi H
and Lin S: Overexpression of FoxM1 promotes differentiation of bone
marrow mesenchymal stem cells into alveolar type II cells through
activating Wnt/β-catenin signaling. Biochem Biophys Res Commun.
528:311–317. 2020.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Perng DW, Yang DM, Hsiao YH, Lo T, Lee OK,
Wu MT, Wu YC and Lee YC: miRNA-146a expression positively regulates
tumor necrosis factor-α-induced interleukin-8 production in
mesenchymal stem cells and differentiated lung epithelial-like
cells. Tissue Eng Part A. 18:2259–2267. 2012.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Chanda D, Rehan M, Smith SR, Dsouza KG,
Wang Y, Bernard K, Kurundkar D, Memula V, Kojima K, Mobley JA, et
al: Mesenchymal stromal cell aging impairs the self-organizing
capacity of lung alveolar epithelial stem cells. Elife.
10(e68049)2021.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Shao Y, Zhou F, He D, Zhang L and Shen J:
Overexpression of CXCR7 promotes mesenchymal stem cells to repair
phosgene-induced acute lung injury in rats. Biomed Pharmacother.
109:1233–1239. 2019.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Huang K, Kang X, Wang X, Wu S, Xiao J, Li
Z, Wu X and Zhang W: Conversion of bone marrow mesenchymal stem
cells into type II alveolar epithelial cells reduces pulmonary
fibrosis by decreasing oxidative stress in rats. Mol Med Rep.
11:1685–1692. 2015.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Mulugeta S and Beers MF: Surfactant
protein C: Its unique properties and emerging immunomodulatory role
in the lung. Microbes Infect. 8:2317–2323. 2006.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Beers MF and Fisher AB: Surfactant protein
C: A review of its unique properties and metabolism. Am J Physiol.
263:L151–L160. 1992.PubMed/NCBI View Article : Google Scholar
|
